SMARCB1 protein and mRNA loss is not caused by promoter and histone hypermethylation in epithelioid sarcoma

[1]  Danbo Wang,et al.  DNA hypomethylation of the COX-2 gene promoter is associated with up-regulation of its mRNA expression in eutopic endometrium of endometriosis , 2012, European Journal of Medical Research.

[2]  T. Nielsen,et al.  Histone deacetylase 1 and 2 in mesenchymal tumors , 2012, Modern Pathology.

[3]  J. Khan,et al.  EZH2 Mediates epigenetic silencing of neuroblastoma suppressor genes CASZ1, CLU, RUNX3, and NGFR. , 2012, Cancer research.

[4]  V. Deltuva,et al.  MGMT, GATA6, CD81, DR4, and CASP8 gene promoter methylation in glioblastoma , 2012, BMC Cancer.

[5]  L. Sullivan,et al.  Malignant Rhabdoid Tumors Express Stem Cell Factors, Which Relate To the Expression of EZH2 and Id Proteins , 2011, The American journal of surgical pathology.

[6]  J. Hornick,et al.  INI1-Deficient Tumors: Diagnostic Features and Molecular Genetics , 2011, The American journal of surgical pathology.

[7]  A. Giordano,et al.  Enhancer of zeste homolog 2 (EZH2) in pediatric soft tissue sarcomas: first implications , 2011, BMC medicine.

[8]  A. Borkhardt,et al.  Epigenetic maintenance of stemness and malignancy in peripheral neuroectodermal tumors by EZH2 , 2009, Cell cycle.

[9]  D. Reisman,et al.  The SWI/SNF complex and cancer , 2009, Oncogene.

[10]  P. D. Dal Cin,et al.  Loss of INI1 Expression is Characteristic of Both Conventional and Proximal-type Epithelioid Sarcoma , 2009, The American journal of surgical pathology.

[11]  Y. Iwamoto,et al.  Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor. , 2009, Human pathology.

[12]  F. Collin,et al.  A Clinicopathologic and Immunohistochemical Analysis of 106 Cases From the French Sarcoma Group , 2009 .

[13]  S. Dhanasekaran,et al.  Repression of E-cadherin by the polycomb group protein EZH2 in cancer , 2008, Oncogene.

[14]  J. Simon,et al.  Roles of the EZH2 histone methyltransferase in cancer epigenetics. , 2008, Mutation research.

[15]  M. Osaki,et al.  High expression of enhancer of zeste homologue 2 indicates poor prognosis in patients with soft tissue sarcomas. , 2008, Molecular medicine reports.

[16]  C. Hother,et al.  MicroRNAs and cancer , 2007, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[17]  Y. Oda,et al.  Highly aggressive behavior of malignant rhabdoid tumor: a special reference to SMARCB1/INI1 gene alterations using molecular genetic analysis including quantitative real-time PCR , 2007, Journal of Cancer Research and Clinical Oncology.

[18]  Silvana Pilotti,et al.  SMARCB1/INI1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas. , 2005, Cancer research.

[19]  S. Belinsky,et al.  Gene-promoter hypermethylation as a biomarker in lung cancer , 2004, Nature Reviews Cancer.

[20]  J. Herman,et al.  Gene silencing in cancer in association with promoter hypermethylation. , 2003, The New England journal of medicine.

[21]  Debashis Ghosh,et al.  EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[22]  S. Dhanasekaran,et al.  The polycomb group protein EZH2 is involved in progression of prostate cancer , 2002, Nature.

[23]  Hengbin Wang,et al.  Role of Histone H3 Lysine 27 Methylation in Polycomb-Group Silencing , 2002, Science.

[24]  J. Biegel,et al.  No evidence for hypermethylation of the hSNF5/INI1 promoter in pediatric rhabdoid tumors , 2002, Genes, chromosomes & cancer.

[25]  Olivier Delattre,et al.  Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer , 1998, Nature.

[26]  G. Crabtree,et al.  Binding and stimulation of HIV-1 integrase by a human homolog of yeast transcription factor SNF5. , 1994, Science.

[27]  A. Menrad,et al.  Establishment and characterization of a cell line (Wa-2) derived from an extrarenal rhabdoid tumor. , 1990, Cancer research.

[28]  F. Enzinger,et al.  Epithelioid sarcoma: Diagnosis, prognostic indicators, and treatment *' † , 1985, The American journal of surgical pathology.

[29]  F. Enzinger.  Epithelioid sarcoma. A sarcoma simulating a granuloma or a carcinoma , 1970 .